Skip to main content

Advertisement

ADVERTISEMENT

Letter to the Editor

Letter to the Editor

January 2022
Wound Manag Prev. 2022;68(1):7

With regard to: Boyar V. Debridement: when, how, and why? Wound Manag Prev. 2021;10:11–14: The author of this article discusses cutting Debrisoft. That is something the manufacturer educates against so that fibers do not shed into the wound.

Thank you,

Aimee McCollam

Director of National Accounts

Lohmann & Rauscher(L&R) USA Inc.

Milwaukee, WI

 

Reply

In this case, the size of the neonatal wound made a smaller size of Debrisoft easier to work with. In addition, I have seen no side effects in my practice with a smaller size, including no visible fibers from the pad. Despite that, I would like to emphasize that the Debrisoft manufacturer does not recommend cutting the product in order to avoid pad fibers contaminating the wound.

Vita Boyar, MD

Director of Neonatal Wound Services

Cohen Children’s Medical Center of New York

New Hyde Park, New York

 

Associate Professor of Pediatrics

Zucker School of Medicine, Hofstra/Northwell

Hempstead, NY

Advertisement

Advertisement

Advertisement